Archives for October 19, 2005

← 2005

Research Dynamics enters CRO service agreement

By  Wai Lang Chu

Research Dynamics have struck a deal with VirtualScopics in which they have signed a non-exclusive partnership agreement to co-market their clinical research services and technologies.

Bionovo identifies hormone therapy drug alternative

By  Wai Lang Chu

Bionovo has announced data identifying a novel class of Oestrogen receptor-subtype modulators, which provides solid evidence of a potentially safer alternative treatment to hormone therapy that treats hot flashes and night sweats.

Growing antibacterial resistance puts R&D in spotlight

By  Wai Lang Chu

According to a new report, the emergence of antibacterial resistance is set to push antibiotic R&D back into the spotlight in an attempt to slow down the increasing levels of drug resistance that could well erode the medical advances of recent decades.

US pharma at all-time low says public

By  Wai Lang Chu

A recently published report has revealed that less than 13 per cent of US consumers believe that information provided by pharmaceutical companies is more trustworthy than healthcare information provided by other organisations.

Dharmacon and Alcon enters RNAi collaboration

By  Wai Lang Chu

Dharmacon and Alcon are to collaborate on the discovery of new therapies for eye disease using RNAi technology. The specificity and novel molecular mechanism of RNAi may allow for the development of safer and more effective drugs targeting previously...